Clinical applications of cardiovascular drugs
著者
書誌事項
Clinical applications of cardiovascular drugs
（Developments in cardiovascular medicine, v. 5）
M. Nijhoff , distributor for the U.S. and Canada, Kluwer Boston, 1980 , distributor for Japan, Igaku Shoin
- : pbk
大学図書館所蔵 件 / 全8件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
- 巻冊次
-
ISBN 9789024722952
内容説明
During the past decade enormous progress has been made in the development of new cardiovascular drugs and in our understanding of the clinical pharma- cology and the pharmacokinetics of old drugs. In addition, newer applications of older agents have emerged. For example, vasodilators such as nitroglycerin are now being employed in the treatment of congestive heart failure, and anti- hypertensives such as bretylium are used in the management of ventricular arrhythmias. Individual chapters in this book focus on (1) the clinical pharmacology and pharmacokinetics of the individual drugs, and (2) the clinical applications of these drugs, with attention also to serum concentrations, pathophysiology, and drug interactions where appropriate. The contributors to this text have labored to provide the reader with a meaningful, practical update on the clinical uses and usefulness of cardioactive drugs. We are deeply grateful to each of them for their generous participation in this endeavor. LEONARD S. DREIFUS, M.D. ALBERT N. BREST, M.D. 1. ANTIARRHYTHMIC AGENTS LEONARD S.
DREIFUS and JOEL MORGANROTH Ideally, the management of cardiac arrhythmias must be predicated on (1) complete elucidation of the genesis of the various rhythm disturbances, and (2) a full understanding of the pharmacologic action of individual antiarrhythmic agents. Only with this precise information does it become possible to administer a particular agent or agents specifically effective against a given arrhythmia.
目次
Antiarrhythmic agents.- Inotropic drugs: cardiac glycosides.- Treatment of cardiogenic shock.- Antianginal drugs.- Vasodilator drugs.- Diuretic drugs.- Antihypertensive drugs.- Antithrombotic drugs.- Hyperlipidemias (hyperlipoproteinemias) and atherosclerosis: pathophysiology and control.
- 巻冊次
-
: pbk ISBN 9789024723690
内容説明
During the past decade enormous progress has been made in the development of new cardiovascular drugs and in our understanding of the clinical pharma cology and the pharmacokinetics of old drugs. In addition, newer applications of older agents have emerged. For example, vasodilators such as nitroglycerin are now being employed in the treatment of congestive heart failure, and anti hypertensives such as bretylium are used in the management of ventricular arrhythmias. Individual chapters in this book focus on (1) the clinical pharmacology and pharmacokinetics of the individual drugs, and (2) the clinical applications of these drugs, with attention also to serum concentrations, pathophysiology, and drug interactions where appropriate. The contributors to this text have labored to provide the reader with a meaningful, practical update on the clinical uses and usefulness of cardioactive drugs. We are deeply grateful to each of them for their generous participation in this endeavor. LEONARD S. DREIFUS, M.D. ALBERT N. BREST, M.D. 1. ANTIARRHYTHMIC AGENTS LEONARD S. DREIFUS and JOEL MORGANROTH Ideally, the management of cardiac arrhythmias must be predicated on (1) complete elucidation of the genesis of the various rhythm disturbances, and (2) a full understanding of the pharmacologic action of individual antiarrhythmic agents. Only with this precise information does it become possible to administer a particular agent or agents specifically effective against a given arrhythmia.
目次
Antiarrhythmic agents.- Inotropic drugs: cardiac glycosides.- Treatment of cardiogenic shock.- Antianginal drugs.- Vasodilator drugs.- Diuretic drugs.- Antihypertensive drugs.- Antithrombotic drugs.- Hyperlipidemias (hyperlipoproteinemias) and atherosclerosis: pathophysiology and control.
「Nielsen BookData」 より